Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 10 » Issue 1

Palliative care in COPD: an unmet area for quality improvement

Authors Vermylen JH, Szmuilowicz E, Kalhan R

Received 25 April 2015

Accepted for publication 23 June 2015

Published 6 August 2015 Volume 2015:10(1) Pages 1543—1551

DOI https://doi.org/10.2147/COPD.S74641

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Editor who approved publication: Dr Richard Russell

Julia H Vermylen,1 Eytan Szmuilowicz,2 Ravi Kalhan3

1Department of Medicine, 2Section of Palliative Medicine, Department of Medicine, 3Asthma and COPD Program, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Abstract: COPD is a leading cause of morbidity and mortality worldwide. Patients suffer from refractory breathlessness, unrecognized anxiety and depression, and decreased quality of life. Palliative care improves symptom management, patient reported health-related quality of life, cost savings, and mortality though the majority of patients with COPD die without access to palliative care. There are many barriers to providing palliative care to patients with COPD including the difficulty in prognosticating a patient’s course causing referrals to occur late in a patient’s disease. Additionally, physicians avoid conversations about advance care planning due to unique communication barriers present with patients with COPD. Lastly, many health systems are not set up to provide trained palliative care physicians to patients with chronic disease including COPD. This review analyzes the above challenges, the available data regarding palliative care applied to the COPD population, and proposes an alternative approach to address the unmet needs of patients with COPD with proactive primary palliative care.

Keywords: advance care planning, primary palliative care, end-of-life care, advanced lung disease, quality of life, prognosis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Green synthesis of silver nanoparticles using cranberry powder aqueous extract: characterization and antimicrobial properties

Ashour AA, Raafat D, El-Gowelli HM, El-Kamel AH

International Journal of Nanomedicine 2015, 10:7207-7221

Published Date: 1 December 2015

Predicting frequent COPD exacerbations using primary care data

Kerkhof M, Freeman D, Jones R, Chisholm A, Price DB

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2439-2450

Published Date: 9 November 2015

Optical birefringence of liquid crystals for label-free optical biosensing diagnosis

Nguyen TT, Han GR, Jang CH, Ju H

International Journal of Nanomedicine 2015, 10:25-32

Published Date: 25 August 2015

Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma

Wei MY, Guo XC, Tu LX, Zou Q, Li Q, Tang CY, Chen B, Xu YH, Wu CB

International Journal of Nanomedicine 2015, 10:5123-5137

Published Date: 12 August 2015

Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels

Yoshizawa T, Okada K, Furuichi S, Ishiguro T, Yoshizawa A, Akahoshi T, Gon Y, Akashiba T, Hosokawa Y, Hashimoto S

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1283-1289

Published Date: 6 July 2015

Lubricin as a novel nanostructured protein coating to reduce fibroblast density

Aninwene II GE, Yang Z, Ravi V, Jay GD, Webster TJ

International Journal of Nanomedicine 2014, 9:3131-3135

Published Date: 25 June 2014